| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.15 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |